Passage Bio Inc (PASG)

Passage Bio Inc (PASG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $11.9M; returns 1 day -4.0%, 1 week -3.7%, 1 year -54.6%.

Passage Bio, Inc. is a clinical-stage genetic medicines company focused on developing transformative, one-time gene therapies for rare, monogenic central nervous system (CNS) disorders. As a clinical-stage entity, it does not generate revenue from product sales; its business model is entirely dependent on research and development funded by capital raises and collaborations.

Groups PASG belongs to

• Clinical Stage Biotech
• Gene Therapy
• Rare Diseases
• Biotechnology
• CNS Disorders
• Neuroscience
• Healthcare
• Biopharmaceutical
• Life Sciences
• Clinical Stage

PASG financial model: income statement, cash flow and balance sheet